Rebranding Repurposing: a Polypharmacological Perspective
“Drug repurposing doesn’t work. We’ve all tried it and it doesn’t work.”
“Drug repurposing doesn’t work. We’ve all tried it and it doesn’t work.”
Over the years, many aspects of Cyclica’s business and technology have changed, sometimes...
The role of a given protein(s) to a specific disease or indication is a fundamental aspect of drug...
Employee Perspective: Cyclica’s Marketing and Communications Specialist, Rebecca Woelfle
A vast majority of protein targets in the human proteome have been deemed undruggable given the...
As innovators, entrepreneurs, and operators, we have a responsibility to ensure that our...
Artificial Intelligence (AI) systems, specifically machine learning (ML) technologies, learn how to...
In this next installment of our AlphaFold Series, we look at the potential drawbacks and...
AlphaFold 2 has provided structures for a large percentage of the proteome, perfectly complementary...
Last Week, DeepMind announced on their blog that they had made available, in collaboration with...